Home LiteratureArticle Details
PMID: 18759922 Published · ppublish English Journal Article Review

Regulation of NK cell responsiveness to achieve self-tolerance and maximal responses to diseased target cells.

Immunological reviews ·Vol. 224 ·2008-08-00 ·Pages 85-97

Joncker NT, Raulet DH

Abstract

Inhibitory receptors specific for major histocompatibility complex (MHC) class I molecules govern the capacity of natural killer (NK) cells to attack class I-deficient cells ('missing-self recognition'). These receptors are expressed stochastically, such that the panel of expressed receptors varies between NK cells. This review addresses how the activity of NK cells is coordinated in the face of this variation to achieve a repertoire that is self-tolerant and optimally reactive with diseased cells. Recent studies show that NK cells arise in normal animals or humans that lack any known inhibitory receptors specific for self-MHC class I. These NK cells exhibit self-tolerance and exhibit functional hyporesponsiveness to stimulation through various activating receptors. Evidence suggests that hyporesponsiveness is induced because these NK cells cannot engage inhibitory MHC class I molecules and are therefore persistently over-stimulated by normal cells in the environment. Finally, we discuss evidence that hyporesponsiveness is a quantitative trait that varies depending on the balance of signals encountered by developing NK cells. Thus, a tuning process determines the functional set-point of NK cells, providing a basis for discriminating self from missing-self, and at the same time endowing each NK cell with the highest inherent responsiveness compatible with self-tolerance.

MeSH Terms
Animals Antigens, CD/immunology Antigens, Surface/immunology Cell Adhesion Molecules/immunology Cytotoxicity, Immunologic Histocompatibility Antigens Class I/genetics,immunology,metabolism Humans Killer Cells, Natural/immunology,metabolism Lectins, C-Type/immunology Lymphocyte Activation/immunology Mice Mice, Transgenic NK Cell Lectin-Like Receptor Subfamily B Receptors, Immunologic/immunology Receptors, KIR/immunology,metabolism Self Tolerance Signaling Lymphocytic Activation Molecule Family T-Lymphocytes, Regulatory/immunology,metabolism Trans-Activators/immunology
Chemicals
Antigens, CD Antigens, Surface CD66 antigens Cd244a protein, mouse Cell Adhesion Molecules Histocompatibility Antigens Class I KLRB1 protein, human KLRG1 protein, human Lectins, C-Type NK Cell Lectin-Like Receptor Subfamily B Receptors, Immunologic Receptors, KIR Signaling Lymphocytic Activation Molecule Family Trans-Activators
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Joncker Nathalie T
Department of Molecular and Cell Biology, University of California Berkeley, Berkeley, CA 94720-3200, USA.
Raulet David H
References (88)
88 references, click to expand
  1. Suppression of natural killer cell-mediated bone marrow cell rejection by CD4+CD25+ regulatory T cells.
    Proc Natl Acad Sci U S A. 2006 Apr 4;103(14):5460-5 PMID: 16567639
  2. The Ly-49 and NKR-P1 gene families encoding lectin-like receptors on natural killer cells: the NK gene complex.
    Annu Rev Immunol. 1993;11:613-35 PMID: 8476574
  3. Mouse Ly-49D recognizes H-2Dd and activates natural killer cell cytotoxicity.
    J Exp Med. 1999 Feb 1;189(3):493-500 PMID: 9927511
  4. CD66a interactions between human melanoma and NK cells: a novel class I MHC-independent inhibitory mechanism of cytotoxicity.
    J Immunol. 2002 Mar 15;168(6):2803-10 PMID: 11884449
  5. MHC-dependent shaping of the inhibitory Ly49 receptor repertoire on NK cells: evidence for a regulated sequential model.
    Eur J Immunol. 2001 Nov;31(11):3370-9 PMID: 11745355
  6. Allelic exclusion of Ly49-family genes encoding class I MHC-specific receptors on NK cells.
    Nature. 1995 Jul 27;376(6538):355-8 PMID: 7630404
  7. 2B4 acts as a non-major histocompatibility complex binding inhibitory receptor on mouse natural killer cells.
    J Exp Med. 2004 May 3;199(9):1245-54 PMID: 15123744
  8. Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors.
    Immunity. 1997 Dec;7(6):739-51 PMID: 9430220
  9. KIR: diverse, rapidly evolving receptors of innate and adaptive immunity.
    Annu Rev Immunol. 2002;20:217-51 PMID: 11861603
  10. Missing self-recognition of Ocil/Clr-b by inhibitory NKR-P1 natural killer cell receptors.
    Proc Natl Acad Sci U S A. 2004 Mar 9;101(10):3527-32 PMID: 14990792
  11. Identification of probabilistic transcriptional switches in the Ly49 gene cluster: a eukaryotic mechanism for selective gene activation.
    Immunity. 2004 Jul;21(1):55-66 PMID: 15345220
  12. Natural killer cell tolerance in mice with mosaic expression of major histocompatibility complex class I transgene.
    J Exp Med. 1997 Aug 4;186(3):353-64 PMID: 9236187
  13. Direct assessment of MHC class I binding by seven Ly49 inhibitory NK cell receptors.
    Immunity. 1999 Jul;11(1):67-77 PMID: 10435580
  14. Altered natural killer cell repertoire in Tap-1 mutant mice.
    Proc Natl Acad Sci U S A. 1994 Jul 5;91(14):6520-4 PMID: 8022815
  15. Turnover and proliferation of NK cells in steady state and lymphopenic conditions.
    J Immunol. 2004 Jan 15;172(2):864-70 PMID: 14707057
  16. CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner.
    J Exp Med. 2005 Oct 17;202(8):1075-85 PMID: 16230475
  17. Natural killer cell education in mice with single or multiple major histocompatibility complex class I molecules.
    J Exp Med. 2005 Apr 4;201(7):1145-55 PMID: 15809355
  18. Function of NKG2D in natural killer cell-mediated rejection of mouse bone marrow grafts.
    Nat Immunol. 2005 Sep;6(9):938-45 PMID: 16086018
  19. Licensing of natural killer cells by self-major histocompatibility complex class I.
    Immunol Rev. 2006 Dec;214:143-54 PMID: 17100882
  20. Expression of different members of the Ly-49 gene family defines distinct natural killer cell subsets and cell adhesion properties.
    J Exp Med. 1994 Dec 1;180(6):2287-95 PMID: 7964501
  21. Molecular cloning of NKB1. A natural killer cell receptor for HLA-B allotypes.
    J Immunol. 1995 Sep 1;155(5):2306-10 PMID: 7650366
  22. Acute rejection of murine bone marrow allografts by natural killer cells and T cells. Differences in kinetics and target antigens recognized.
    J Exp Med. 1987 Nov 1;166(5):1499-509 PMID: 3316472
  23. Biological function of the soluble CEACAM1 protein and implications in TAP2-deficient patients.
    Eur J Immunol. 2004 Aug;34(8):2138-48 PMID: 15259011
  24. MHC class I deficiency: susceptibility to natural killer (NK) cells and impaired NK activity.
    Science. 1991 Jul 12;253(5016):199-202 PMID: 1853205
  25. NK susceptibility varies inversely with target cell class I HLA antigen expression.
    J Immunol. 1987 Mar 15;138(6):1657-9 PMID: 3819393
  26. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C.
    Nature. 1998 Feb 19;391(6669):795-9 PMID: 9486650
  27. Antigen-activated human T lymphocytes express cell-surface NKG2D ligands via an ATM/ATR-dependent mechanism and become susceptible to autologous NK- cell lysis.
    Blood. 2007 Jul 15;110(2):606-15 PMID: 17405908
  28. Self-tolerance of human natural killer cells lacking self-HLA-specific inhibitory receptors.
    Scand J Immunol. 2008 Mar;67(3):218-29 PMID: 18226015
  29. Mouse CD94/NKG2A is a natural killer cell receptor for the nonclassical major histocompatibility complex (MHC) class I molecule Qa-1(b).
    J Exp Med. 1998 Nov 16;188(10):1841-8 PMID: 9815261
  30. In search of the 'missing self': MHC molecules and NK cell recognition.
    Immunol Today. 1990 Jul;11(7):237-44 PMID: 2201309
  31. Model for the in vivo assembly of nascent Ld class I molecules and for the expression of unfolded Ld molecules at the cell surface.
    J Exp Med. 1993 Dec 1;178(6):2035-46 PMID: 8245780
  32. Low number of H-2Dd-negative haematopoietic cells in mixed bone marrow chimeras convey in vivo tolerance to H-2Dd-negative cells but fail to prevent resistance to H-2Dd-negative leukaemia.
    Scand J Immunol. 2004 Jan;59(1):71-8 PMID: 14723624
  33. MAFA-L, an ITIM-containing receptor encoded by the human NK cell gene complex and expressed by basophils and NK cells.
    Eur J Immunol. 1998 Nov;28(11):3755-62 PMID: 9842918
  34. NK cell expression of the killer cell lectin-like receptor G1 (KLRG1), the mouse homolog of MAFA, is modulated by MHC class I molecules.
    Eur J Immunol. 2000 Mar;30(3):920-30 PMID: 10741410
  35. Self-tolerance of natural killer cells.
    Nat Rev Immunol. 2006 Jul;6(7):520-31 PMID: 16799471
  36. Acquisition of Ly49 receptor expression by developing natural killer cells.
    J Exp Med. 1998 Feb 16;187(4):609-18 PMID: 9463411
  37. Interaction of Ly-49D+ NK cells with H-2Dd target cells leads to Dap-12 phosphorylation and IFN-gamma secretion.
    J Immunol. 2000 Jan 15;164(2):603-11 PMID: 10623801
  38. Cutting edge: identification of E-cadherin as a ligand for the murine killer cell lectin-like receptor G1.
    J Immunol. 2006 Feb 1;176(3):1311-5 PMID: 16424155
  39. Regulation of the natural killer cell receptor repertoire.
    Annu Rev Immunol. 2001;19:291-330 PMID: 11244039
  40. 2B4 (CD244)-CD48 interactions provide a novel MHC class I-independent system for NK-cell self-tolerance in mice.
    Blood. 2005 Aug 15;106(4):1337-40 PMID: 15870174
  41. Roles of the NKG2D immunoreceptor and its ligands.
    Nat Rev Immunol. 2003 Oct;3(10):781-90 PMID: 14523385
  42. MHC class I alloantigen specificity of Ly-49+ IL-2-activated natural killer cells.
    Nature. 1992 Jul 2;358(6381):66-70 PMID: 1614533
  43. Licensing of natural killer cells by host major histocompatibility complex class I molecules.
    Nature. 2005 Aug 4;436(7051):709-13 PMID: 16079848
  44. A new self: MHC-class-I-independent natural-killer-cell self-tolerance.
    Nat Rev Immunol. 2005 May;5(5):363-74 PMID: 15841099
  45. Major histocompatibility complex genes determine natural killer cell tolerance.
    Eur J Immunol. 1996 Jan;26(1):151-5 PMID: 8566058
  46. Expression of natural killer receptor alleles at different Ly49 loci occurs independently and is regulated by major histocompatibility complex class I molecules.
    J Exp Med. 2001 Feb 5;193(3):307-15 PMID: 11157051
  47. Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells.
    Science. 1995 Apr 21;268(5209):405-8 PMID: 7716543
  48. Hierarchy of the human natural killer cell response is determined by class and quantity of inhibitory receptors for self-HLA-B and HLA-C ligands.
    J Immunol. 2007 Nov 1;179(9):5977-89 PMID: 17947671
  49. The basis for self-tolerance of natural killer cells in beta2-microglobulin- and TAP-1- mice.
    J Immunol. 1997 Dec 1;159(11):5219-25 PMID: 9548460
  50. NK cell recognition.
    Annu Rev Immunol. 2005;23:225-74 PMID: 15771571
  51. P58 molecules as putative receptors for major histocompatibility complex (MHC) class I molecules in human natural killer (NK) cells. Anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specificities.
    J Exp Med. 1993 Aug 1;178(2):597-604 PMID: 8340759
  52. Impaired natural killing of MHC class I-deficient targets by NK cells expressing a catalytically inactive form of SHP-1.
    J Immunol. 2000 Aug 1;165(3):1314-21 PMID: 10903732
  53. Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains.
    Immunity. 1995 May;2(5):439-49 PMID: 7749980
  54. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy.
    Nature. 1986 Feb 20-26;319(6055):675-8 PMID: 3951539
  55. Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic acid allogeneic tumors. I. Distribution of reactivity and specificity.
    Int J Cancer. 1975 Aug 15;16(2):216-29 PMID: 50294
  56. Specificity, tolerance and developmental regulation of natural killer cells defined by expression of class I-specific Ly49 receptors.
    Immunol Rev. 1997 Feb;155:41-52 PMID: 9059881
  57. Evidence for a similar or common mechanism for natural killer cell activity and resistance to hemopoietic grafts.
    Eur J Immunol. 1977 Sep;7(9):655-63 PMID: 336380
  58. Rejection of class I MHC-deficient haemopoietic cells by irradiated MHC-matched mice.
    Nature. 1991 Jan 24;349(6307):329-31 PMID: 1987491
  59. Recognition of beta 2-microglobulin-negative (beta 2m-) T-cell blasts by natural killer cells from normal but not from beta 2m- mice: nonresponsiveness controlled by beta 2m- bone marrow in chimeric mice.
    Proc Natl Acad Sci U S A. 1991 Nov 15;88(22):10332-6 PMID: 1946452
  60. Sustained localized expression of ligand for the activating NKG2D receptor impairs natural cytotoxicity in vivo and reduces tumor immunosurveillance.
    Nat Immunol. 2005 Sep;6(9):928-37 PMID: 16116470
  61. Major histocompatibility complex class I-dependent skewing of the natural killer cell Ly49 receptor repertoire.
    Eur J Immunol. 1996 Oct;26(10):2286-92 PMID: 8898935
  62. Clonal acquisition of inhibitory Ly49 receptors on developing NK cells is successively restricted and regulated by stromal class I MHC.
    Immunity. 2000 Jul;13(1):143-53 PMID: 10933402
  63. Cumulative inhibition of NK cells and T cells resulting from engagement of multiple inhibitory Ly49 receptors.
    J Immunol. 2001 Mar 1;166(5):3002-7 PMID: 11207249
  64. Analysis of natural killer cells in TAP2-deficient patients: expression of functional triggering receptors and evidence for the existence of inhibitory receptor(s) that prevent lysis of normal autologous cells.
    Blood. 2002 Mar 1;99(5):1723-9 PMID: 11861289
  65. How do natural killer cells find self to achieve tolerance?
    Immunity. 2006 Mar;24(3):249-57 PMID: 16546094
  66. Systemic NKG2D down-regulation impairs NK and CD8 T cell responses in vivo.
    J Immunol. 2005 Jul 15;175(2):720-9 PMID: 16002667
  67. Major histocompatibility complex class I antigens and the control of viral infections by natural killer cells.
    J Virol. 1995 Jul;69(7):3967-71 PMID: 7769654
  68. Modulation of sensitivity to natural killer cell lysis after in vitro explantation of a mouse lymphoma.
    J Natl Cancer Inst. 1978 Dec;61(6):1495-8 PMID: 281556
  69. Human NK cell education by inhibitory receptors for MHC class I.
    Immunity. 2006 Aug;25(2):331-42 PMID: 16901727
  70. Class I-deficient hemopoietic cells and nonhemopoietic cells dominantly induce unresponsiveness of natural killer cells to class I-deficient bone marrow cell grafts.
    J Immunol. 1997 Feb 15;158(4):1628-33 PMID: 9029098
  71. Strategies for target cell recognition by natural killer cells.
    Immunol Rev. 2001 Jun;181:170-84 PMID: 11513138
  72. Host resistance directed selectively against H-2-deficient lymphoma variants. Analysis of the mechanism.
    J Exp Med. 1985 Dec 1;162(6):1745-59 PMID: 3877776
  73. Genetically linked C-type lectin-related ligands for the NKRP1 family of natural killer cell receptors.
    Nat Immunol. 2003 Aug;4(8):801-7 PMID: 12858173
  74. Killer cell lectin-like receptor G1 binds three members of the classical cadherin family to inhibit NK cell cytotoxicity.
    J Exp Med. 2006 Feb 20;203(2):289-95 PMID: 16461340
  75. Direct and indirect interactions of the cytoplasmic region of CD244 (2B4) in mice and humans with FYN kinase.
    J Biol Chem. 2007 Aug 31;282(35):25385-94 PMID: 17599905
  76. Positive impact of inhibitory Ly49 receptor-MHC class I interaction on NK cell development.
    J Immunol. 2000 Jul 1;165(1):91-5 PMID: 10861039
  77. Positive recognition of MHC class I molecules by the Ly49D receptor of murine NK cells.
    J Immunol. 1999 Feb 15;162(4):2035-43 PMID: 9973475
  78. Genomic Ly49A transgenes: basis of variegated Ly49A gene expression and identification of a critical regulatory element.
    J Immunol. 2004 Jan 15;172(2):1074-82 PMID: 14707081
  79. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis.
    Annu Rev Immunol. 2001;19:197-223 PMID: 11244035
  80. Beta 2-microglobulin deficient mice lack CD4-8+ cytolytic T cells.
    Nature. 1990 Apr 19;344(6268):742-6 PMID: 2139497
  81. MHC class Ia molecules alone control NK-mediated bone marrow graft rejection.
    Eur J Immunol. 1999 Nov;29(11):3683-90 PMID: 10556824
  82. Host MHC class I gene control of NK-cell specificity in the mouse.
    Immunol Rev. 1997 Feb;155:11-28 PMID: 9059879
  83. Activity and phenotype of natural killer cells in peptide transporter (TAP)-deficient patients (type I bare lymphocyte syndrome).
    J Exp Med. 1998 Jan 5;187(1):117-22 PMID: 9419217
  84. 2F1 antigen, the mouse homolog of the rat "mast cell function-associated antigen", is a lectin-like type II transmembrane receptor expressed by natural killer cells.
    Eur J Immunol. 1998 Dec;28(12):4409-17 PMID: 9862378
  85. "Natural" killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype.
    Eur J Immunol. 1975 Feb;5(2):112-7 PMID: 1234049
  86. CD4+CD25+ T regulatory cells suppress NK cell-mediated immunotherapy of cancer.
    J Immunol. 2006 Feb 1;176(3):1582-7 PMID: 16424187
  87. Functionally conformed free class I heavy chains exist on the surface of beta 2 microglobulin negative cells.
    J Exp Med. 1992 Sep 1;176(3):829-34 PMID: 1512546
  88. A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules.
    Blood. 2005 Jun 1;105(11):4416-23 PMID: 15728129
Article Info
Journal
Immunological reviews
Abbr.
Immunol Rev
ISSN
1600-065X
Published
2008-08-00
Pages
85-97
Language
English
Region
England
NLM ID
7702118
PMCID
PMC3017429
Subset
IM
Grants
NIAID NIH HHS · R01 AI035021-08 · United States
NIAID NIH HHS · R01 AI039642-08 · United States
NCI NIH HHS · R01 CA093678-08 · United States
NIAID NIH HHS · R01 AI039642 · United States
NIAID NIH HHS · R01 AI035021 · United States
NCI NIH HHS · R01 CA093678 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com